Skip to main content

ScholarsBetaWeill Cornell Medicine

Browse About Sign in

Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Loading search results…

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research6

FiltersClear all

Status

Recruiting3
Active, not recruiting2
Completed1

Study type

Interventional6

Phase

Not applicable6

Investigator

Shmuel Chen6
Jim W. Cheung10
Brian DeRubertis8
James E. Ip8
Geoffrey W Bergman6

Show all 50

Department

Medicine6

Condition

Tricuspid Valve Insufficiency3
Heart Valve Diseases2
Aortic Valve Insufficiency1
Aortic Valve Stenosis1
Cardiovascular Diseases1

Intervention type

Device6
Drug2

Sponsor type

Industry6

Start date

to

Has results posted1

Shmuel Chen×Device×Clear all

Showing 1–6 of 6 studiesSort:

RecruitingInterventional · Not applicableNCT04097145 ↗
A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation

Show fewer

Show all 7

Show fewer

Heart Failure1
Mitral Valve Insufficiency1

Intervention: Device: Edwards PASCAL System · Drug: Optimal Medical Therapy
Dates: Dec 2019 – Dec 2027 (est.)
Sponsor: Edwards Lifesciences Corp.

Tricuspid RegurgitationTricuspid Valve InsufficiencyTricuspid Valve Disease

Active, not recruitingInterventional · Not applicableNCT04153292 ↗

SAPIEN M3 System Transcatheter Mitral Valve Replacement Via Transseptal Access

Intervention: Device: SAPIEN M3 valve and dock
Dates: Nov 2020 – Oct 2027 (est.)
Sponsor: Edwards Lifesciences Corp.

Mitral RegurgitationMitral Valve Insufficiency

Active, not recruitingInterventional · Not applicableNCT04482062 ↗

Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device

Intervention: Device: Edwards EVOQUE System · Drug: Optimal Medical Therapy
Dates: Apr 2021 – Dec 2025
Sponsor: Edwards Lifesciences Corp.

Tricuspid Valve RegurgitationTricuspid Valve InsufficiencyTricuspid Valve Disease+3 more

RecruitingInterventional · Not applicableNCT05172973 ↗

Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves

Intervention: Device: SAPIEN X4/X4S THV
Dates: Nov 2023 – Mar 2029 (est.)
Sponsor: Edwards Lifesciences Corp.

Aortic Valve InsufficiencyAortic Valve Stenosis

RecruitingInterventional · Not applicableNCT06212193 ↗

Early Feasibility Study (EFS) to Assess the Safety and Performance of the Innoventric Trillium™ Stent Graft in the Treatment of Severe or Greater Tricuspid Regurgitation (TR)

Intervention: Device: Trillium™
Dates: Aug 2024 – Dec 2026 (est.)
Sponsor: Innoventric LTD

Tricuspid RegurgitationTricuspid Regurgitation Functional

CompletedInterventional · Not applicableNCT04618718 ↗

Cerebral Protection in Transcatheter Aortic Valve Replacement - The PROTEMBO C Trial

Intervention: Device: cerebral embolic protection during TAVR
Dates: Jul 2020 – Nov 2022· Results posted
Sponsor: Protembis GmbH

Valvular Heart Disease